Last reviewed · How we verify

NCT03484936: SERIC-sICH

Safety and Efficacy of Remote Ischemic Conditioning in Patients With Spontaneous Intracerebral Hemorrhage

Not yet recruiting NA Last updated 2 October 2024
What this trial tests

NA trial testing Remote ischemic conditioning in Intracranial Hemorrhages in 530 participants. Not yet recruiting.

Timeline
15 March 2026
Primary endpoint
15 September 2026
15 June 2027

Quick facts

Lead sponsorYi Yang
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment530
Start date15 March 2026
Primary completion15 September 2026
Estimated completion15 June 2027
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Yi Yang — full company profile →

Who can join

18 and older, any sex, with Intracranial Hemorrhages. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine whether treatment with remote ischemic conditioning is of sufficient promise to improve outcome before conducting a larger clinical trial to examine its effectiveness as a treatment for intracerebral hemorrhage.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Remote Ischemic Conditioning for Intracerebral Hemorrhage (RICH-1): Rationale and Study Protocol for a Pilot Open-Label Randomized Controlled Trial.
    Zhao W, Jiang F, Li S, Wu C, et al · · 2020 · cited 15× · PMID 32411082 · DOI 10.3389/fneur.2020.00313

Verify or expand the search:

Other trials of Remote ischemic conditioning

Trials testing the same drug.

Other recruiting trials for Intracranial Hemorrhages

Currently open trials in the same condition.

Other Yi Yang trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03484936.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing